Real-world use and effectiveness of fostemsavir in a US clinical setting: Insights from Trio Health HIV Research Network. (PubMed, HIV Med) - Sep 23, 2026 - "In this real-world, diverse cohort, FTR was well tolerated, with high persistence and, in the dispensing-data subset, high adherence. It effectively maintained viral suppression among suppressed individuals and provided immunologic benefits across subgroups, including viremic initiators. These findings support FTR as a valuable treatment option for heavily treatment-experienced PWH."
Journal • Real-world evidence • Human Immunodeficiency Virus • Infectious Disease • CD4
|
|
Andrew Frick; Cassidy Henegar; Charles Walworth; Gregory Huhn; Isobel McEwen; Karam Mounzer; Leigh Ragone; Moti Ramgopal; Richard Elion; Steven Santiago; Vani Vannappagari
|